Machavert develops a new class of therapies to help the human body to fight various diseases such as cancer or autoimmune disorders. Machavert focuses on preclinical research to build up a portfolio of drug candidates for clinical trials.
Company (Alive / Active)
12635 E. Montview Blvd.
Colorado, United States
|Investor||Investor Type||Location||Participating Rounds|